The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer

(IDIBELL-Bellvitge Biomedical Research Institute) Recent research results from the European consortium IT-Liver provide a better understanding of the role of the TGF-beta cytokine in liver cancer. Their work, published in Cancer Letters, shows how the TGF-beta cytokine is able to modulate not only the migratory capacity of the hepatocellular carcinoma cell but also its capacity as a tumor initiator cell.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news